My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
Education & Training Resources Practice Guidelines Journals & Publications Policy & Advocacy Meetings About IDSA
November 2014
Patient Care and Science
Now Available: Updated Guideline for Kidney Disease in HIV Patients

An updated HIVMA and IDSA guideline for the treatment of chronic kidney disease in patients infected with HIV is available online. Published in the Nov. 1 issue of Clinical Infectious Diseases, the new document updates guidance last issued in 2005.

Antiretroviral therapy (ART) is beneficial for the 5 to 10 percent of HIV-infected patients with reduced kidney function, with the exception of tenofovir—the most widely prescribed ART—which can lead to moderate kidney damage in some patients, according to the updated guideline.

“Research shows HIV patients who have clinically decreased kidney function are less likely to be prescribed ART, probably because physicians and other health care providers are concerned that many of these medications are cleared by the kidneys and don’t want to cause further harm,” said Gregory Lucas, MD, associate professor at Johns Hopkins School of Medicine and co-chair of the guideline panel. “But the outlook for HIV patients with kidney disease is much better now that we have numerous effective treatments for HIV, many of which are not cleared by the kidneys.”

The guideline also recommends kidney transplantation as a viable option in HIV-infected patients whose kidneys are failing. Despite previous concerns that these patients would not fare well on the immunosuppressive therapy necessary to prevent the body from rejecting the organ, initial research suggests they are as likely to survive and maintain a functioning organ as transplant recipients without HIV infection.

Those caring for HIV patients should monitor both kidney function, by estimating glomerular filtration rate (GFR), and kidney damage, with urinalysis or urine protein, the guideline recommends. As many as one in 10 people with HIV have decreased kidney function, and up to twice as many may have other evidence of kidney damage.

Mobile device and pocket-card versions of the updated guideline are available for use at the point of care. These and other clinical tools can be accessed through the practice guidelines section of the IDSA website.

Next Article >

Post a comment

Your name:

Your comment:

Patient Care and Science
Now Available: Updated Guideline for Kidney Disease in HIV Patients
FDA Approves First Combination Pill for HCV
EIN Update: Tracking the Enterovirus D68 Outbreak
Clinical Practice Management
HIV Provider Resources: Outpatient Billing and Coding; ACOs and HIV Care
Policy and Advocacy
IDSA Testifies Before Congress on Antimicrobial Resistance
IDSA Urges Boost in Funding for Public Health Agencies in FY 2016 Budget
Society Calls for More Funding of ID Comparative Effectiveness Research
Global ID
On the Frontlines of the HIV/TB Response in Africa: Impacts and Gaps
Live from Cape Town and Barcelona: Biomedical HIV Prevention and the Fight Against TB
You and Your Colleagues
Members on the Move
New Members
Education and Resources
HIV Minority Clinical Fellowship Program: December 12 Application Deadline
Top Stories
From the President
The State of the Society: Reports from IDWeek 2014 Business Meeting
IDWeek 2014: Post Meeting Resources
Congratulations to the 2014 Society Award Winners!
IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add '' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.